Clincosm LogoSign in Get a demo

Glioblastoma

Showing NaN - NaN of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)

Recruiting
  • Glioblastoma
  • Adult-type Diffuse Gliomas
  • Beverly Hills, California
  • +83 more
Jul 25, 2022

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

Glioblastoma Multiforme, Glioblastoma Trial in United States (biological, procedure, drug)

Not yet recruiting
  • Glioblastoma Multiforme
  • Glioblastoma
  • IGV-001 Cell Immunotherapy
  • +3 more
  • Newark, Delaware
  • +22 more
Jun 24, 2022

Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)

Active, not recruiting
  • Brain Tumor, Recurrent
  • +4 more
  • Cytoreductive surgery
  • +2 more
  • New York, New York
  • +1 more
Jun 9, 2022

Glioblastoma, Glioblastoma Multiforme Trial in United States (drug, other, radiation)

Recruiting
  • Glioblastoma
  • Glioblastoma Multiforme
  • Los Angeles, California
  • +3 more
May 31, 2022

Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

Active, not recruiting
  • Glioblastoma Multiforme
  • +6 more
  • Dendritic cell immunotherapy
  • Birmingham, Alabama
  • +85 more
May 12, 2022

Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant Trial in New York (Repeated Superselective Intraarterial Cerebral

Recruiting
  • Glioblastoma
  • +6 more
  • Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation
  • Temozolomide and Radiation Alone
  • New York, New York
    Lenox Hill Brain Tumor Center
May 5, 2022

Glioblastoma Trial in Worldwide (DSP-7888 Dosing Emulsion, Bevacizumab)

Active, not recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +60 more
Apr 4, 2022

Glioblastoma Trial in New York, Calgary, Toronto (BBI608, Temozolomide)

Completed
Has Results
  • Glioblastoma
  • New York, New York
  • +2 more
Apr 4, 2022

Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma

Active, not recruiting
  • Glioblastoma
    • Birmingham, Alabama
    • +18 more
    Mar 7, 2022

    Glioblastoma Trial in New York (Paxalisib, Metformin, Ketogenic Diet)

    Not yet recruiting
    • Glioblastoma
    • New York, New York
      Weill Cornell Medicine
    Dec 20, 2021

    Glioblastoma, GBM Trial in New York (Avelumab, MRI-guided LITT therapy)

    Completed
    • Glioblastoma
    • GBM
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Dec 31, 2021

    Glioblastoma Trial in New York (Ketogenic Diet, Metformin)

    Recruiting
    • Glioblastoma
    • New York, New York
    • +1 more
    Dec 21, 2021

    Coping With Glioblastoma: A Study of Communication Between

    Active, not recruiting
    • Brain Cancer
    • Glioblastoma
    • psychometric tests, questionnaires and neurocognitive assessments
    • Detroit, Michigan
    • +7 more
    Dec 16, 2021

    Glioblastoma Trial in United States (Ad-RTS-hIL-12, Veledimex, Cemiplimab-Rwlc)

    Completed
    • Glioblastoma
    • Ad-RTS-hIL-12
    • +2 more
    • Los Angeles, California
    • +6 more
    Nov 3, 2021

    Glioblastoma, Brain Cancer, Brain Tumor Trial in New York (Intra-arterial Cetuximab, Intra-arterial Mannitol)

    Recruiting
    • Glioblastoma
    • +6 more
    • Intra-arterial Cetuximab
    • Intra-arterial Mannitol
    • New York, New York
      Lenox Hill Brain Tumor Center
    Oct 27, 2021

    Glioblastoma, Glioblastoma Multiforme, GBM Trial in New York (Tissue autograft of pedicled temporoparietal fascial (TPF) or

    Recruiting
    • Glioblastoma
    • +3 more
    • Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
    • New York, New York
      Lenox Hill Brain Tumor Center
    Oct 27, 2021

    Glioblastoma Trial in United States (Ad-RTS-hIL-12, veledimex)

    Completed
    • Glioblastoma
    • Los Angeles, California
    • +3 more
    Sep 21, 2021

    Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in France, Netherlands, United States (AMG 232)

    Completed
    • Advanced Malignancy
    • +7 more
    • AMG 232
    • Santa Monica, California
    • +13 more
    Aug 30, 2021

    Glioblastoma Multiforme (GBM), Glioblastoma, Glioma of Brain Trial in New York (Capecitabine, Temozolomide)

    Recruiting
    • Glioblastoma Multiforme (GBM)
    • +8 more
    • New York, New York
      Lenox Hill Brain Tumor Center
    Aug 30, 2021

    Glioblastoma Trial in United States (Trans Sodium Crocetinate plus SOC, Standard of Care (SOC))

    Terminated
    Has Results
    • Glioblastoma
    • Trans Sodium Crocetinate plus SOC
    • Standard of Care (SOC)
    • Irvine, California
    • +12 more
    Jul 1, 2021

    Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)

    Completed
    • Brain Cancer
    • +10 more
    • DNX-2401
    • pembrolizumab
    • Little Rock, Arkansas
    • +14 more
    Jul 13, 2021

    Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)

    Recruiting
    • Cancer, Metastatic
    • +42 more
    • Clinical Trial Matching
    • New York, New York
      Massive Bio, Inc
    May 21, 2021

    Glioblastoma Trial in United States (Pembrolizumab, Bevacizumab)

    Completed
    Has Results
    • Glioblastoma
    • Los Angeles, California
    • +7 more
    Nov 30, 2020

    Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

    Terminated
    Has Results
    • Malignant Melanoma
    • +7 more
    • Gilbert, Arizona
    • +29 more
    Sep 21, 2020